Ola Bratt
-
2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic
Review
O. Bergengren, K. R. Pekala, K. Matsoukas, J. Fainberg, S. F. Mungovan, Ola Bratt, F. Bray, O. Brawley, A. N. Luckenbaugh, L. Mucci, T. M. Morgan, Sigrid Carlsson
European Urology - 2023 -
How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022
declaration
O. Majek, M. Babjuk, M. J. Roobol, Ola Bratt, H. Van Poppel, R. Zachoval, J. Ferda, M. Koudelkova, O. Ngo, J. Gregor, S. Collen, K. Hejduk, L. Dusek, V. Valek
European Urology Open Science - 2023 -
Men's Perception of Being Invited for Prostate Cancer Testing and the Information About Its Pros and Cons-A Survey from Two Population-based Testing
Programmes
Linda Svensson, Karin Stinesen Bratt, T. Jiborn, A. C. Borjedahl, Ola Bratt
European Urology Open Science - 2023 -
Re: Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy
Only.
Ola Bratt, Anssi Auvinen
European urology - 2023 -
The Long and Winding Road from Guideline Recommendations to Improved Quality of
Care.
Ola Bratt
European urology - 2023 -
First diagnostic results from Gothenburg-2 screening
trial.
Ola Bratt, Anssi Auvinen
Scandinavian journal of urology - 2023 -
Clinical Value of a Routine Urine Culture Prior to Transrectal Prostate
Biopsy
Joakim Örtegren, A. Wimmerstedt, D. Åberg, H. Janson, Henrik Kjölhede, G. Kahlmeter, Ola Bratt
European Urology Open Science - 2023 -
Integrating magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography/computed tomography results into prostate cancer treatment decision
making.
Ola Bratt
BJU international - 2022 -
Is it time to abandon routine antibiotics for transperineal prostate
biopsy?
Ola Bratt
The Lancet. Infectious diseases - 2022 -
Designing and Implementing a Population-based Organised Prostate Cancer Testing
Programme.
Max Alterbeck, Emil Järbur, Erik Thimansson, Jonas Wallström, Johan Bengtsson, Thomas Björk-Eriksson, Anders Bjartell, Ola Bratt, Thomas Jiborn, Rebecka Arnsrud Godtman
European urology focus - 2022 -
Low-grade prostate cancer should still be labelled
cancer.
Kenneth A Iczkowski, Mariel Molina, Lars Egevad, David G Bostwick, Geert J L H van Leenders, Francisco G La Rosa, Theodorus van der Kwast, Daniel M Berney, Andrew J Evans, Thomas M Wheeler, Katia R M Leite, Hemamali Samaratunga, John Srigley, Murali Varma, Toyonori Tsuzuki, Marshall Scott Lucia, Elward David Crawford, Richard G Harris, Philip Stricker, Nathan Lawrentschuk, Henry H Woo, Neil E Fleshner, Neal D Shore, John Yaxley, Ola Bratt, Peter Wiklund, Matthew Roberts, Liang Cheng, Brett Delahunt
BJU international - 2022 -
The Swedish national guidelines on prostate cancer, part 2: recurrent, metastatic and castration resistant
disease
Ola Bratt, S. Carlsson, P. Fransson, J. Kindblom, Johan Stranne, C. T. Karlsson
Scandinavian Journal of Urology - 2022 -
Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in
Sweden.
Eugenio Ventimiglia, Anna Bill-Axelson, Ola Bratt, Francesco Montorsi, Pär Stattin, Hans Garmo
JAMA network open - 2022 -
The Swedish national guidelines on prostate cancer, part 1: early detection, diagnostics, staging, patient support and primary management of non-metastatic
disease
Ola Bratt, S. Carlsson, P. Fransson, C. T. Karlsson, Johan Stranne, J. Kindblom
Scandinavian Journal of Urology - 2022 -
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and Ga-68-PSMA-PET for biochemical relapse after radical prostatectomy-The PROPER 1
trial
A. Gunnlaugsson, V. Johannesson, E. Wieslander, E. Brun, U. Bitzen, O. Stahl, Ola Bratt, G. Ahlgren, T. Ohlsson, E. Kjellen, P. Nilsson
Clinical and Translational Radiation Oncology - 2022 -
Rates of Positive Abdominal Computed Tomography and Bone Scan Findings Among Men with Cambridge Prognostic Group 4 or 5 prostate cancer: A Nationwide Registry
Study
C. Stenman, E. Abrahamsson, M. Redsater, V. J. Gnanapragasam, Ola Bratt
European Urology Open Science - 2022 -
Experience Measures after Radical Prostatectomy: A Register-Based Study Evaluating the Association between Patient-Reported Symptoms and Quality of
Information
O. Christiansen, O. Kirkevold, Ola Bratt, J. S. Benth, M. Slaaen
Healthcare - 2022 -
The provision of prostate cancer patient information leaflets on an electronic tablet: A further step to paperless health-care
provision
S. Miah, J. Maw, K. Pang, V. Nair, S. Hori, A. Lamb, A. Martin, Ola Bratt, B. Lamb, N. M. Shah
Urology Annals - 2022 -
Predictors of upgrading from low-grade cancer at prostatectomy in men with biparametric magnetic resonance
imaging
O. Christiansen, Ola Bratt, O. Kirkevold, J. S. Benth, P. Manoharan, A. Selnes, E. S. Haug, M. Slaaen
Central European Journal of Urology - 2022 -
Quality of life in men with metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone: a systematic review and
meta-analysis
K. K. Ternov, A. B. Nolsoe, Ola Bratt, M. Fode, H. Lindberg, C. Kistorp, G. Palapattu, T. W. Klausen, J. Sonksen, P. B. Ostergren
Prostate Cancer and Prostatic Diseases - 2021 -
Has the time come for routine use of PET/CT for guiding treatment of biochemical recurrence after radical
prostatectomy?
Ola Bratt
Scandinavian Journal of Urology - 2021 -
Construct Validity of the Questionnaire Quality From the Patients Perspective Adapted for Surgical Prostate Cancer
Patients.
Ola Christiansen, Jūratė Šaltytė Benth, Øyvind Kirkevold, Ola Bratt, Marit Slaaen
Journal of patient experience - 2021 -
Predictors of histological upgrading at radical prostatectomy in patients with localised low-grade prostate cancer and pretreatment biparametric
MRI
Ola Christiansen, Øyvind Kirkevold , Ola Bratt, Jūratė Šaltytė Benth , Pathmakulendran Manoharan, Anders Selnes , Erik Skaaheim Haug , Marit Slaaen
Central European Journal of Urology - 2021 -
Modern prostate cancer diagnostics reduce overdiagnosis - will they open up for population-based
screening?
Ola Bratt, Hans Lilja
Scandinavian journal of urology - 2021 -
Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19
pandemic
G. Fallara, F. Sandin, J. Styrke, S. Carlsson, Ingela Franck Lissbrant, J. Ahlgren, Ola Bratt, M. Lambe, P. Stattin
Scandinavian Journal of Urology - 2021 -
Prostate biopsy quality and patient experience with the novel Forsvall biopsy needle - a randomized controlled non-inferiority
trial
A. Forsvall, J. Fisher, M. Wagenius, C. Broman, D. Korkocic, Ola Bratt, A. Linder
Scandinavian Journal of Urology - 2021 -
Evaluation of the Forsvall biopsy needle in an ex vivo model of transrectal prostate biopsy - a novel needle design with the objective to reduce the risk of post-biopsy
infection
A. Forsvall, J. Fisher, J. F. P. Cardoso, M. Wagenius, J. Tverring, B. Nilson, A. Dahlin, Ola Bratt, A. Linder, T. Mohanty
Scandinavian Journal of Urology - 2021 -
Rate and characteristics of infection after transrectal prostate biopsy: a retrospective observational
study
A. Forsvall, H. Jonsson, M. Wagenius, Ola Bratt, A. Linder
Scandinavian Journal of Urology - 2021 -
PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome - 5 year follow-up of a prospective observational
study
Adalsteinn Gunnlaugsson, Elisabeth Kjellén, Göran Ahlgren, Ola Bratt, Vilberg Johannesson, René Blom, Per Nilsson
Clinical and translational radiation oncology - 2020 -
The value of a first MRI and targeted biopsies after several years of active surveillance for low-risk prostate cancer - results from the SAMS
trial
S. Carlsson, Ola Bratt, D. Kristiansson, F. Jaderling
Scandinavian Journal of Urology - 2020 -
Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year
journey
Johan Stranne, Elin Axén, Ingela Franck Lissbrant, P. Fransson, Maria Frånlund, Jonas Hugosson, Ali Khatami, Katarina Koss-Modig, Pär Lodding, Maria Nyberg, P. Stattin, Ola Bratt
World Journal of Urology - 2020 -
Changes in lifestyle among prostate cancer survivors: A nationwide population-based
study
O. Bergengren, A. P. Enblad, H. Garmo, Ola Bratt, L. Holmberg, E. Johansson, A. Bill-Axelson
Psycho-Oncology - 2020 -
Risk of Postoperative Up Staging or Upgrading among Men with Low Risk Familial Prostate
Cancer
F. Jansson, F. Folkvaljon, P. Stattin, Ola Bratt, O. Akre
Journal of Urology - 2020 -
Comparative performance and external validation of the multivariable PREDICTProstatetool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden
(PCBaSe)
D. Thurtle, Ola Bratt, P. Stattin, P. Pharoah, V. Gnanapragasam
Bmc Medicine - 2020 -
Prostate cancer in kidney transplant recipients - a nationwide register
study
Ola Bratt, L. Drevin, K. G. Prutz, S. Carlsson, L. Wennberg, P. Stattin
Bju International - 2020 -
Optimising the number of cores for magnetic resonance imaging-guided targeted and systematic transperineal prostate
biopsy
N. L. Hansen, T. Barrett, T. Lloyd, A. Warren, C. Samel, Ola Bratt, C. Kastner
Bju International - 2020 -
TECLA-an innovative technical approach for prostate cancer
registries.
Ola Christiansen, Ola Bratt, Erik Skaaheim Haug, Arild Vaktskjold, Anders Selnes, Marit Jordhøy
Scandinavian journal of urology - 2019 -
Development and validation of a prediction model for identifying men with intermediate- or high-risk prostate cancer for whom bone imaging is unnecessary: a nation-wide population-based
study
Rebecka Arnsrud Godtman, Marianne Månsson, Ola Bratt, D. Robinsson, E. Johansson, P. Stattin, Henrik Kjölhede
Scandinavian Journal of Urology - 2019 -
Determinants for choosing and adhering to active surveillance for localised prostate cancer: A nationwide population-based
study
O. Bergengren, H. Garmo, Ola Bratt, L. Holmberg, E. Johansson, A. Bill-Axelson
BMJ Open - 2019 -
Defining the incremental value of 3D T2-weighted imaging in the assessment of prostate cancer extracapsular
extension.
Iztok Caglic, Petra Povalej Brzan, Anne Y Warren, Ola Bratt, Nimish Shah, Tristan Barrett
European radiology - 2019 -
A randomised trial comparing two protocols for transrectal prostate repeat biopsy: six lateral posterior plus six anterior cores versus a standard posterior 12-core
biopsy
Joakim Örtegren, J. T. Holmberg, E. Lekas, S. Maria, S. Martensson, J. Richthoff, P. Sundqvist, Henrik Kjölhede, Ola Bratt, F. Liedberg
Scandinavian Journal of Urology - 2019 -
Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate
cancer
V. J. Gnanapragasam, T. Barrett, V. Thankapannair, D. Thurtle, J. Rubio-Briones, J. Domínguez-Escrig, Ola Bratt, P. Statin, K. Muir, A. Lophatananon
Bju International - 2019 -
PCASTt/SPCG-17-A randomised trial of active surveillance in prostate cancer: Rationale and
design
Mats Steinholtz Ahlberg, Hans Olov Adami, Kerri Beckmann, Helena Bertilsson, Ola Bratt, Declan Cahill, Lars Egevad, Hans Garmo, Lars Holmberg, Eva Johansson, Antti Rannikko, Mieke Van Hemelrijck, Fredrik Jäderling, Cecilia Wassberg, Ulrika W.N. Åberg, Anna Bill-Axelson
BMJ Open - 2019 -
The Value of an Extensive Transrectal Repeat Biopsy with Anterior Sampling in Men on Active Surveillance for Low-risk Prostate Cancer: A Comparison from the Randomised Study of Active Monitoring in Sweden
(SAMS)
Ola Bratt, E. Holmberg, O. Andren, S. Carlsson, L. Drevin, E. Johansson, A. Josefsson, M. Nyberg, J. Sandberg, P. Stattin, D. Robinsson
European Urology - 2019 -
Androgen deprivation therapy for prostate cancer and risk of
dementia
D. Robinson, H. Garmo, M. Van Hemelrijck, Jan-Erik Damber, Ola Bratt, L. Holmberg, L. O. Wahlund, P. Stattin, J. Adolfsson
Bju International - 2019 -
Defining Intermediate-Risk Prostate Cancer Suitable for Active
Surveillance.
Stacy Loeb, Yasin Folkvaljon, Ola Bratt, David Robinson, Pär Stattin
The Journal of urology - 2019 -
The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation
study.
V J Gnanapragasam, Ola Bratt, K Muir, L S Lee, H H Huang, P Stattin, A Lophatananon
BMC medicine - 2018 -
Genetic Reasons to Walk the Extra Mile to Prevent Prostate
Cancer.
Ola Bratt, Alastair D Lamb
European urology - 2018 -
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based
Study
O. Bergengren, H. Garmo, Ola Bratt, L. Holmberg, E. Johansson, A. Bill-Axelson
European Urology Oncology - 2018 -
Quantification of Total and Intracellular Sodium Concentration in Primary Prostate Cancer and Adjacent Normal Prostate Tissue With Magnetic Resonance
Imaging.
Tristan Barrett, Frank Riemer, Mary A McLean, Josh Kaggie, Fraser Robb, James S Tropp, Anne Warren, Ola Bratt, Nimish Shah, Vincent J Gnanapragasam, Fiona J Gilbert, Martin J Graves, Ferdia A Gallagher
Investigative radiology - 2018 -
Nationwide, population-based study of post radical prostatectomy urinary incontinence correction
surgery.
Eugenio Ventimiglia, Yasin Folkvaljon, Stefan Carlsson, Ola Bratt, Francesco Montorsi, Daniela Volz, Olof Akre, Eva Johansson, Pär Stattin
Journal of surgical oncology - 2018 -
Pre-treatment 18F-choline PET/CT is prognostic for biochemical recurrence, development of bone metastasis, and cancer specific mortality following radical local therapy of high-risk prostate
cancer.
Henrik Kjölhede, Helén Almquist, Kerstin Lyttkens, Ola Bratt
European journal of hybrid imaging - 2018 -
A paradigm shift for prostate cancer
diagnostics
Ola Bratt
Lakartidningen - 2018 -
Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic
Review
N. Kinsella, P. Stattin, D. Cahill, C. Brown, A. Bill-Axelson, Ola Bratt, Sigrid Carlsson, M. Van Hemelrijck
European Urology - 2018 -
Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate
Cancer
F. Jansson, L. Drevin, T. Frisell, P. Stattin, Ola Bratt, O. Akre
Journal of Clinical Oncology - 2018